Home › Research › Down syndrome and Alzheimer's
Brain cognition and metabolism in Down syndrome adults in association with development of dementia
Dani A, Pietrini P, Furey ML, McIntosh AR, Grady CL, Horwitz B, Freo U, Alexander GE et al.. Neuroreport, 1996-11-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
To identify changes in brain functions associated with the development of dementia, brain metabolism and cognition were assessed repeatedly in 12 adults with Down syndrome (DS) using positron emission tomography and neuropsychological tests. Ten subjects remained non-demented (ND) and showed no significant changes over time in cognitive measures or in cerebral metabolism. Two subjects developed dementia after 7 years. Brain functions were relatively stable prior to the onset of dementia; after the onset of dementia, both cognitive function and glucose metabolism in parietal and temporal brain regions known to be vulnerable to Alzheimer disease (AD) showed a rapid linear decline. These findings support the concept that brain functions are stable over time in ND individuals with DS and that decline of brain functions in DS subjects with dementia follows two distinct phases that correspond to the clinical progression of AD. This may have implications for timing of new therapeutic strategies.
What this study adds
Evidence grade: Low
This is a trial of 12 participants. In 12 adults with Down syndrome followed over time, the 10 who did not develop dementia showed no significant changes in cognition or brain metabolism, while the 2 who developed dementia declined rapidly afterward. This small study suggests brain function stays stable until dementia begins, which may help with timing of future treatments.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Dani, A., Pietrini, P., Furey, M. L., McIntosh, A. R., Grady, C. L., Horwitz, B., et al. (1996). Brain cognition and metabolism in Down syndrome adults in association with development of dementia. Neuroreport. https://doi.org/10.1097/00001756-199611250-00026
Vancouver
Dani A, Pietrini P, Furey ML, McIntosh AR, Grady CL, Horwitz B, et al. Brain cognition and metabolism in Down syndrome adults in association with development of dementia. Neuroreport. 1996. doi:10.1097/00001756-199611250-00026. PMID: 9116213.
BibTeX
@article{dani1996-9116213,
author = {Dani, A. and Pietrini, P. and Furey, M. L. and McIntosh, A. R. and Grady, C. L. and Horwitz, B. and Freo, U. and Alexander, G. E. and others},
title = {{Brain cognition and metabolism in Down syndrome adults in association with development of dementia}},
journal = {Neuroreport},
year = {1996},
doi = {10.1097/00001756-199611250-00026},
pmid = {9116213},
url = {https://doi.org/10.1097/00001756-199611250-00026}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- To identify changes in brain functions associated with the development of dementia, brain metabolism and cognition were assessed repeatedly in 12 adults with Down syndrome (DS) using positron emission tomography and neuropsychological tests.
- Ten subjects remained non-demented (ND) and showed no significant changes over time in cognitive measures or in cerebral metabolism.
- These findings support the concept that brain functions are stable over time in ND individuals with DS and that decline of brain functions in DS subjects with dementia follows two distinct phases that correspond to the clinical progression of AD.
Why it matters
In 12 adults with Down syndrome followed over time, the 10 who did not develop dementia showed no significant changes in cognition or brain metabolism, while the 2 who developed dementia declined rapidly afterward. This small study suggests brain function stays stable until dementia begins, which may help with timing of future treatments.
Study details
- Participants12
- Evidence strengthLow
How this study scored 40/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neuroreport) |
| Journal's citation record | 2 / 4 | Neuroreport: journal h-index 242 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1996 — older than 20 years, still counted |
| Sample size | 1 / 4 | 12 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 30 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.9 citations a year over 32 year(s) since 1996 |
| Impact for its field and year | 2 / 6 | Cited 2.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Mark B. Schapiro: h-index 56 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | National Institutes of Health: institution h-index 2,723 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 9116213) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 40 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.